泻下通腑法在慢性阻塞性肺疾病急性加重期的应用
|
摘要
慢性阻塞性肺疾病(Chronic Obstructive Pulmonary Disease,以下简称COPD)是一种全球性患病率、病死率较高的和可预防的慢性呼吸系统疾病。COPD呈慢性进行性发展的过程,又容易在感染等因素的作用下出现慢性阻塞性肺疾病急性发作(Acute Exacerbations of Chronic Obstructive Pulmonary Disease,以下简称AECOPD),出现咳嗽、咳痰、气短和(或)喘息加重,痰量增多,呈脓性或黏脓性,可伴发热等炎症明显加重的表现。目前普遍认为COPD以气道、肺实质和肺血管的慢性炎症为特征。而气道炎症在原有基础上的加重是AECOPD的一个特征。AECOPD的嗜酸粒细胞、中性粒细胞较稳定期增加,释放多种炎症介质,导致TNF-α、IL-6、IL-8等水平升高,从而破坏肺的结构和(或)促进中性粒细胞炎症反应,使肺功能下降。同时,氧化应激也是炎症反应的重要步骤,是COPD患者气道炎症存在的主要原因。COPD可归属于中医“喘证”、“肺胀”范畴。感邪则偏于邪实。AECOPD的证型以“痰热壅肺型”为主。肺与大肠相表里,肺热易移于肠腑,导致肠腑传导失司,而肠腑传导失司也可以加重肺脏病症。因而,肺邪热移于肠腑,热邪耗液,大肠津亏,邪热与燥屎相结而成实,故大便干结。腑实热结上迫于肺,使肺气不降,肺气不降则大肠腑气不通,二者互为因果而成恶性循环。现代医家根据“肺与大肠相表里”的理论,运用“通腑泻热法”治疗AECOPD,取得了一定效果,但研究集中在灌肠方面,也有汤剂口服者,但组方变化复杂,亦未运用肺功能等更客观的指标进行评价,故未能规范、系统评价研究“泻下通腑法”
目的：通过规范、系统的症状评分联合肺功能检测,评估“泻下通腑”法在治疗AECOPD中的效果,为合理运用“泻下通腑法”治疗AECOPD提供更多的、科学的临床研究依据。
方法：收集年龄在40岁或以上,75岁或以下,住院确诊为AECOPD“肺热腑实型”的患者共60例,将其随机分为治疗组和对照组。两组均予相同的西医基础治疗,治疗组加用“泻下通腑”法的小承气汤治疗。小承气汤治疗,每3日评估,每病例最多治疗9天。患者缓解时观察疗效,用Microsoft Excel建立数据库,用SPSS 11.5进行统计分析,用t检验及卡方检验比较治疗前后患者临床症状、体征、大便、肺功能的差异及两组疗效差异。
结果：住院患者以男性居多,发病年龄以71-75岁居多。治疗后,两组的临床症状、体征改善均较显著,两组的临床症状、体征改善均较显著,治疗组达88.76%,对照组达72.87%；而疗效则治疗组平均达90.0±15.54%,对照组亦达75.0±22.63%,两组间临床症状、体征、大便情况、肺功能(FEV1、FEV1%)、疗效、缓解天数(相差2.77天)经卡方及t检验存在统计学差异。
结论：AECOPD住院的痰热壅肺型患者多数有大便干结的腑气不通的临床表现。运用中医“泻下通腑法”的小承气汤结合西医基础治疗,提示临床症状、体征、大便、FEV1、FEV1%的均有更好的改善,有更好的疗效,能促进患者更早缓解急性加重期,从而减轻肺功能损害,减少社会经济负担。通过肺功能结合临床症状、体征等评价中医“泻下通腑”法可以为临床提供更客观、更规范的研究依据。
Chronic Obstructive Pulmonary Disease is a respiratory disease that h as a higher morbidity and mortality, and can be preventable and treatable. COPD demonstrates a course that develops chronicly and progressively. It c an be exacerbated by infection and develops into Acute Exacerbations of C hronic Obstructive Pulmonary Disease, with the obviously exacerbating imfl ammations of cough, sputum production and worsening dyspnea, more sputum, pu rulent or sticky-purulent, fever, etc. As now, it is thought that COPD is c haracterized with imflammations in the proximal airways, peripheral airway s, lung parenchyma, or pulmonary vasculature. The imfammation exacerbated in the respiratory tract is one of the feature of AECOPD. The steadily incr eased neutrophil and eosinophil cells periodically in AECOPD, releasing mu ltiple inflammatory mediators, will lead to the leveling of TNF-a, IL-6, IL-8 and the destroying of the pumonal structure or the promoting of the im flammation of the neutrophil cells, deteriorating the pumonal functions, Me anwhile, oxidative stress is an important step of the inflammation and th e majoy cause of the exsisting inflammation of the respiratory tract in t he COPD patients. Oxidative stress is further increased in exacerbations. C OPD can be categorized to Panting syndrome or Lung Distension in traditio nal Chinese medicine (TCM).It becomes a state of evil domination when exo genous evil attacks. AECOPD mainly manifests the type of accumulation of s putum-heat in the lung of the differentiation of Syndromes in the traddio nal chinese medicine. As the lung and the large intestine are interior-ext eriorly related, the dry-heat in the lung wil easely move down to the larg e intestine, resulting the disturbance of large intestine intransport whic h may exacerbate the pulmonary disease. Thus, when the dry-heat in the lung moves down to the large intestine, heat evil burns body fluid, lessening f luid in the intestine, and combines dry stool mutually, so dry stool appear. excessive heat of the large intestine viscera transfers up to oppress the lung, so that the Lung-Qi can't descend, and then the Qi of large intestin e viscera stagnates, the two become cause and effect mutually to develop a vicious circle.The modern TCM doctors treat COPD by using The method of Purging to relax the bowels,based on the theory of the lung and the large intestine being interior-exteriorly related, and have acheived some certa in results. But their researches focus on the clysis, while there is decoct ion-form taken orally, however, the prescripions are various and complex, an d can not be evaluated by more objective indicators like the pulmonary fu nctions.So, the method of Purging to relax the bowels has not been resear ched or evaluated standardizedly and systematically.
Objective:The therapeutic effects of the method of Purging to relax the bowels in the treatment of AECOPD are evaluated by combining the sc ores of standardized and systematic symptoms with the examination of pul monary functions, so that provides more and scientific clinic evidence fo r reasonable application of The method of Purging to relax the bowels.
Method:Collect 60 inpatients who were diagnosed the heat-lung and t he excess-Fu-organ in accordance with the criterion of AECOPD syndrome, w hose age varies from 40 to 75. They were divided into the therapeutic gro up and the controlled group. The former was treated with Xiaochengqi deco ction of the method of Purging to relax the bowels of TCM, combining with basal treatment of mordern-western medicine, while the latter was just t reated with basal treatment of mordern-western medicine. The course of th e treatment of the Xiaochengqi decoction is three days, which was divided into three part. The therapeutic effect is observed before the disease r elieve, calculating the data with Microsofe Excel 2003 and carrying out s tatistic analysis with SPSS 11.0, using t-test and chi-square test to com pare the differences of the clinic symptom, sign, constipation, pulmonary function and therapeutic effect of the two group between the therapeutic before and aft.
Result:The majority of inpatients are man and whose age varies betw een 71 and 75. After treatment, the improvement of clincic symptoms and s igns of both groups are obvious. The improvement rate of the therapeutic group is 88.76%, reaching a average of therapeutic efficiency of 90.0±1 5.54%, while the improvement rate of the controlled group is 72.87%, rea ching a average of therapeutic efficiency of 75.0±22.63%. There are diff erences between the two group of the clincic symptoms, signs, feces, pulmon ary function (FEV1, FEV1%), therapeutic efficiency, days of relief by t-te st and chi-square test.
Conclusion:Most inpatients of the type of the accumulation of sputu m-heat in the lung manifest constipation of the excess-Fu-organ.The the rapeutic group applying the therapy of Xiaochengqi decoction of the meth od of Purging to relax the bowels of TCM combined with basal treatment o f mordern-western medicine shows better improvements and therapeutic eff ects than the controlled group,which relieves the inpatients'exacerbat ion earlier,reduce the injury of the pulmonary function and the econom ic burdens of the society.To evaluate the method of Purging to relax the bowels of TCM by combining the clinic symptom and sign with the examina tion of the pulmonary function can provide more objective and standardiz ed researching evidence for the clinic practice.
目的：通过规范、系统的症状评分联合肺功能检测,评估“泻下通腑”法在治疗AECOPD中的效果,为合理运用“泻下通腑法”治疗AECOPD提供更多的、科学的临床研究依据。
方法：收集年龄在40岁或以上,75岁或以下,住院确诊为AECOPD“肺热腑实型”的患者共60例,将其随机分为治疗组和对照组。两组均予相同的西医基础治疗,治疗组加用“泻下通腑”法的小承气汤治疗。小承气汤治疗,每3日评估,每病例最多治疗9天。患者缓解时观察疗效,用Microsoft Excel建立数据库,用SPSS 11.5进行统计分析,用t检验及卡方检验比较治疗前后患者临床症状、体征、大便、肺功能的差异及两组疗效差异。
结果：住院患者以男性居多,发病年龄以71-75岁居多。治疗后,两组的临床症状、体征改善均较显著,两组的临床症状、体征改善均较显著,治疗组达88.76%,对照组达72.87%；而疗效则治疗组平均达90.0±15.54%,对照组亦达75.0±22.63%,两组间临床症状、体征、大便情况、肺功能(FEV1、FEV1%)、疗效、缓解天数(相差2.77天)经卡方及t检验存在统计学差异。
结论：AECOPD住院的痰热壅肺型患者多数有大便干结的腑气不通的临床表现。运用中医“泻下通腑法”的小承气汤结合西医基础治疗,提示临床症状、体征、大便、FEV1、FEV1%的均有更好的改善,有更好的疗效,能促进患者更早缓解急性加重期,从而减轻肺功能损害,减少社会经济负担。通过肺功能结合临床症状、体征等评价中医“泻下通腑”法可以为临床提供更客观、更规范的研究依据。
Chronic Obstructive Pulmonary Disease is a respiratory disease that h as a higher morbidity and mortality, and can be preventable and treatable. COPD demonstrates a course that develops chronicly and progressively. It c an be exacerbated by infection and develops into Acute Exacerbations of C hronic Obstructive Pulmonary Disease, with the obviously exacerbating imfl ammations of cough, sputum production and worsening dyspnea, more sputum, pu rulent or sticky-purulent, fever, etc. As now, it is thought that COPD is c haracterized with imflammations in the proximal airways, peripheral airway s, lung parenchyma, or pulmonary vasculature. The imfammation exacerbated in the respiratory tract is one of the feature of AECOPD. The steadily incr eased neutrophil and eosinophil cells periodically in AECOPD, releasing mu ltiple inflammatory mediators, will lead to the leveling of TNF-a, IL-6, IL-8 and the destroying of the pumonal structure or the promoting of the im flammation of the neutrophil cells, deteriorating the pumonal functions, Me anwhile, oxidative stress is an important step of the inflammation and th e majoy cause of the exsisting inflammation of the respiratory tract in t he COPD patients. Oxidative stress is further increased in exacerbations. C OPD can be categorized to Panting syndrome or Lung Distension in traditio nal Chinese medicine (TCM).It becomes a state of evil domination when exo genous evil attacks. AECOPD mainly manifests the type of accumulation of s putum-heat in the lung of the differentiation of Syndromes in the traddio nal chinese medicine. As the lung and the large intestine are interior-ext eriorly related, the dry-heat in the lung wil easely move down to the larg e intestine, resulting the disturbance of large intestine intransport whic h may exacerbate the pulmonary disease. Thus, when the dry-heat in the lung moves down to the large intestine, heat evil burns body fluid, lessening f luid in the intestine, and combines dry stool mutually, so dry stool appear. excessive heat of the large intestine viscera transfers up to oppress the lung, so that the Lung-Qi can't descend, and then the Qi of large intestin e viscera stagnates, the two become cause and effect mutually to develop a vicious circle.The modern TCM doctors treat COPD by using The method of Purging to relax the bowels,based on the theory of the lung and the large intestine being interior-exteriorly related, and have acheived some certa in results. But their researches focus on the clysis, while there is decoct ion-form taken orally, however, the prescripions are various and complex, an d can not be evaluated by more objective indicators like the pulmonary fu nctions.So, the method of Purging to relax the bowels has not been resear ched or evaluated standardizedly and systematically.
Objective:The therapeutic effects of the method of Purging to relax the bowels in the treatment of AECOPD are evaluated by combining the sc ores of standardized and systematic symptoms with the examination of pul monary functions, so that provides more and scientific clinic evidence fo r reasonable application of The method of Purging to relax the bowels.
Method:Collect 60 inpatients who were diagnosed the heat-lung and t he excess-Fu-organ in accordance with the criterion of AECOPD syndrome, w hose age varies from 40 to 75. They were divided into the therapeutic gro up and the controlled group. The former was treated with Xiaochengqi deco ction of the method of Purging to relax the bowels of TCM, combining with basal treatment of mordern-western medicine, while the latter was just t reated with basal treatment of mordern-western medicine. The course of th e treatment of the Xiaochengqi decoction is three days, which was divided into three part. The therapeutic effect is observed before the disease r elieve, calculating the data with Microsofe Excel 2003 and carrying out s tatistic analysis with SPSS 11.0, using t-test and chi-square test to com pare the differences of the clinic symptom, sign, constipation, pulmonary function and therapeutic effect of the two group between the therapeutic before and aft.
Result:The majority of inpatients are man and whose age varies betw een 71 and 75. After treatment, the improvement of clincic symptoms and s igns of both groups are obvious. The improvement rate of the therapeutic group is 88.76%, reaching a average of therapeutic efficiency of 90.0±1 5.54%, while the improvement rate of the controlled group is 72.87%, rea ching a average of therapeutic efficiency of 75.0±22.63%. There are diff erences between the two group of the clincic symptoms, signs, feces, pulmon ary function (FEV1, FEV1%), therapeutic efficiency, days of relief by t-te st and chi-square test.
Conclusion:Most inpatients of the type of the accumulation of sputu m-heat in the lung manifest constipation of the excess-Fu-organ.The the rapeutic group applying the therapy of Xiaochengqi decoction of the meth od of Purging to relax the bowels of TCM combined with basal treatment o f mordern-western medicine shows better improvements and therapeutic eff ects than the controlled group,which relieves the inpatients'exacerbat ion earlier,reduce the injury of the pulmonary function and the econom ic burdens of the society.To evaluate the method of Purging to relax the bowels of TCM by combining the clinic symptom and sign with the examina tion of the pulmonary function can provide more objective and standardiz ed researching evidence for the clinic practice.
引文
[1]中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2007年修订版).中华内科杂志,2007；46(3)：254.
[2]Anthonisen NR etal. Antibiotic therapy in exacerbations of chronic ob structive pulmonary disease. Ann Intern Med,1987; 106(2):1962-204.
[3]唐昊,修清玉.慢性阻塞性肺疾病急性加重的研究.国际呼吸杂志,2007；27(3)：225-229.
[4]Bhowmik A, Seemungal A R, Sapsford J, etal. Relation of sputum inflam matory markers to symptoms and lung function changes in COPD exacerb ations. Thorax,2000; 55:114-120.
[5]Montuschi P. Exhaled 8-iso-sprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am Respir Crit Care Med,2000; 162:1175-1177.
[6]White AJ, Gompertz S, Stockley R A.Chronic obstructive pulmonary dis ease 6:Theaetiology of exacerbations of chronic obstructive pulmonar y disease. Thorax,2003; 58(1):73-80.
[7]A. Sonia Buist,etal. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease(2006)GOLD. Execut ive Committee.
[8]王景红,顾媛媛.2005-2007年我院慢性阻塞性肺疾病住院患者用药分析.中国医院用药评价与分析,2008；8(7)：502-505.
[9]侯冬青.老年慢性阻塞性肺病患者医院肺炎病原菌及耐药性分析.中国现代医学杂志,2006；16(7)：1083-1085.
[10]王秀香,杨敬平,卜宝英.老年COPD并社区获得性肺炎常见病原菌及耐药性分析.临床肺科杂志,2008；13(4)：426-427.
[11]程萍.老年COPD患者并发社区获得性肺炎常见病原菌及其耐药性分析.山东医药,2008；48(16)：52.
[12]马兴璇,刘春明,雷保中,等COPD急性加重期患者支气管肺泡灌洗液细菌培养及药敏结果分析.检验医学,2008；23(5)：525-527.
[13]欧阳瑶.慢性阻塞性肺疾病患者非发酵菌感染及耐药谱分析.中国综合临床,2003；19(7)：624-625.
[14]任亚娟.老年慢性阻塞性肺疾病急性加重期216例下呼吸道病原菌分析.陕西医学杂志,2008；37(9)：1165-1167.
[15]樊春月.COPD下呼吸道感染主要致病菌种耐药现状.临床肺科杂志,2008；13(1)：59-61.
[16]赵德军,付维婵,田维涛,等.老年COPD患者并发肺部真菌感染的相关因素分析及控制对策.西南军医,2008；10(5)：39.
[17]银春.茶碱的作用机制及在慢性阻塞性肺疾病中的应用.临床肺科杂志,2008；13(7)：885-887.
[18]赵健.糖皮质激素短期治疗AECOPD的临床疗效观察.中国医药导报,2008；5(11)：61.
[19]任建萍.慢性阻塞性肺疾病的经济负担及其影响因素研究.卫生经济研究,2002；10：16-17.
[20]叶静辉,李惠玲,郭瑞霞,等.慢性阻塞性肺疾病急性加重期经济负担与防治现状的卫生经济学分析中国预防医学杂志,2005；6(4)：364-366.
[21]李建生.中药治疗COPD急性加重期的系统评价.天津中医药,2008；25(5)：428-432.
[22]王贵勤.痰热清注射液治疗慢性阻塞性肺病急性加重期的临床观察.中国现代医生,2007；45(13)：146-147.
[23]谷春燕.中西医结合治疗慢性阻塞性肺疾病疗效分析.中国民康医学,2007；19(9)：759.
[24]梁爱武.冬屏汤冬病夏治对慢性阻塞性肺疾病稳定期免疫功能影响的观察.广西中医学院学报,2008;11(1)：9-11.
[25]李树强.中医治疗慢性阻塞性肺疾病研究概况.实用中医药杂志,2006；22(4)：248-249.
[26]孙子凯,曹世宏.262例慢性阻塞性肺疾病证治规律探讨.南京中医药大学学报,1998；14(1)：13-15.
[27]田正鉴,徐幼明,李亚清.慢性阻塞性肺疾病中医病机探微.湖北中医学院学报,2001；3(1)：29-30.
[28]薛汉荣.中医论治慢性阻塞性肺病.江西中医学院学报,2004；16(6)：13.
[29]田德禄主编.中医内科学,北京：人民卫生出版社,2006,第1版：98.
[30]王至婉.基于文献的慢性阻塞性肺疾病稳定期证候诊断标准研究.中医研究,2008;21(8)：55-58.
[31]黄东晖,吴蕾,何德平,等.中西医综合治疗慢性阻塞性肺疾病稳定期临床观察.第四军医大学学报,2005；26(17)：1611-1613.
[32]张颖,高鹏飞,方忠宏,等.益肺健脾补肾法为主防治慢性阻塞性肺疾病的疗效观察.中国中医基础医学杂志,2004；10(6)：56-57.
[33]刘小虹,刘琼.培土生金法在慢性阻塞性肺疾病缓解期的应用研究.新中医, 2002；34(10)：18.
[34]王胜,季红燕,张念志,等.益肺健脾方对炎症细胞计数和慢性阻塞性肺疾病患者痰液IL-8、TNF-a水平的影响.中国中西医结合杂志,2005；25(2)：111-113.
[35]王胜,季红燕,张念志,等.益肺健脾中药改善慢性阻塞性肺疾病患者肺功能及营养状况.中国临床康复,,2005；31(9)：141-143.
[36]朱渊红,王新华,朱奕豪,等.益气健脾方对慢性阻塞性肺病营养状态的影响.中国中西医结合杂志,2005；25(8)：759-760.
[37]李海明,张华茹.银杏叶片治疗慢性阻塞性肺疾病稳定期疗效观察.现代中西医结合杂志,2004；13(2)：146.
[38]李兴文,杨玉萍,方利洲,等.云南白药对稳定期慢性阻塞性肺疾病痰液炎性细胞调控研究.中国新药杂志,2001；10(4)：282-284.
[39]朱文翔.益气养阴法治疗肺胀病.湖北中医杂志,1996；(3)：41.
[40]朱频,郦永平.慢性阻塞性肺疾病急性加重期中医证治规律探讨.河南中医,1998；18(6)：369.
[41]陈凯佳.500例慢性阻塞性肺疾病中医证型规律探讨.现代中西医结合杂志,2002；11(18)：1755-1757.
[42]蔡敏.定掌汤治疗慢阻肺急性发作期160例临床研究.江苏中医药,2005；26(12)：18-19.
[43]陈艳波,王华,刘华,等.痰热清注射液治疗慢性阻塞性肺疾病临床研究.中国中医急症,2005；14(7)：620-621.
[44]崔焱,梁直英,董竞成.活血化瘀方治疗慢性阻塞性肺疾病急性加重期的临床观察.中国中西医结合杂志,2005；25(4)：327-329.
[45]林琳,方泓,吴银根.加味已椒苈黄汤治疗COPD肺动脉高压的临床研究.上海中医药杂志,2005；39(6)：24-25.
[46]付泽伟,王晓君.中西医结合治疗慢性阻塞性肺疾病继发真菌感染疗效观察.湖北中医杂志,2005；27(9)：36-37.
[47]史锁芳.COPD发作期治疗方案及组方新构想.中国中医药信息杂志,1998；5(12)：3-4.
[48]张元兵,洪广祥.“肺与大肠相表里”理论在慢性阻塞性肺疾病急性发作期的应用.江西中医药,2000；31(3)：15-17.
[49]李兴锋.下法在内科急症中的应用.实用中医内科杂志,2004；18(4)：328.
[50]李秀彦.通腑降浊法治疗慢性阻塞性肺疾病呼吸衰竭的疗效观察.河北中医,2006；28(7)：503-504.
[51]方堃.通腑平喘汤联合机械通气治疗慢性阻塞性肺疾病并发呼吸衰竭的临床疗效观察.中国中西医结合急救杂志,2006；13(5)：291-293.
[52]方堃.通腑平喘汤对COPD机械通气患者呼吸力学的作用.浙江中西医结合杂志,2008；18(8)：466-468.
[53]刘宇.益气通腑汤对脱机困难的COPD患者的临床研究.河南大学学报(医学科学版),2002；21(2)：29-31.
[54]张英兰.中药灌肠合无创通气治疗COPD并呼吸衰竭临床观察.实用中西医结合临床,2008；8(3)：13-14.
[55]林婕钊,韩云,李芳.通下法配合无创通气治疗慢性阻塞性肺疾病急性加重期呼吸衰竭15例.新中医,2005；37(1)：41-42.
[56]宋应西.通腑化瘀法治疗轻型肺性脑病31例.河南中医学院学报,2006；5：50-51.
[57]汪丙柱.从肺与大肠相表里论治慢性阻塞性肺疾病稳定期的临床观察.中国中医药信息杂志,2008；15(9)：76-77.
[58]陈宏,支开叶,冯五金.通腑泻热法治疗AECOPD128例临床观察.山西中医,2008；24(6)：29-30.
[59]张文东.小承气汤合清金化痰汤治疗慢性阻塞性肺疾病急性加重期42例.中医药临床杂志,2008；20(1)：39-40.
[60]韦蓉.通腑法治疗慢性阻塞性肺疾病继发缺氧性肺动脉高压疗效观察.中国中医急症,2007；16(11)：1311-1313.
[61]刘军.大承气汤治疗慢性阻塞性肺病腹胀的临床观察.临床肺科杂志,2007；12(11)：1188.
[62]王今达.祖国医学“肺与大肠相表里”学说的临床意义及其本质探讨.中西医结合杂志,1982；2(2)：77-78.
[63]王辉,郑水红,曹樟全.小承气汤对危重症腹胀患者呼吸功能的影响.浙江中西医结合杂志,2002;12(8)：482-483.
[64]苗裕,杨进.“肺与大肠相表里”理论论述及临床应用浅析.中国医药导报,2009；15(12)：7-9.
[65]韦慧,史肃育,吴同启.通腑法治疗慢性阻塞性肺疾病继发缺氧性肺动脉高压疗效观察.中国中医急症,2007；16(11)：1311.
[66]范仁忠.论通里泻下法在急重病证中的运用.中国中医急症,2000；9(2)：66-67.
[67]崔杰.小承气汤治疗慢性阻塞性肺病急性期的体会.河南中医,1999；19(4)：12.
[68]于德敏,范喜云.大黄对肺心病并发胃肠道衰竭的治疗观察.临床荟萃,1999；14(13)：614.
[69]张文东,许有志,金莉.小承气汤合清金化痰汤治疗慢性阻塞性肺疾病急性加重期42例.中医药临床杂志,2008；20(1)：39-40.
[70]李广彬.小承气汤的现代药理与临床应用.中国医药指南,2008；6(15)：136-137.
[71]杨岚,梁一木,陈明霞,等.氧化与抗氧化失衡对慢性阻塞性肺病患者外周血 淋巴细胞线粒体膜磷脂改变的研究.陕西医学杂志,1998；27(10)：589～592.
[72]李春盛,何新华,桂培春.大黄对急性肺损伤大鼠血浆和支气管肺泡灌洗液中炎症细胞因子表达的影响.中国中西医结合急救杂志,2005；12(5)：306-308.
[73]李贞茂,韩盛玺,徐志鹏,等.厚朴酚对大鼠坏死性胰腺炎肺损伤的保护作用.世界华人消化杂志,2006；14(12)：1167-1171.
[74]王立青,江荣高,陈蕙芳.厚朴酚与和厚朴酚药理作用的研究进展.中草药,2005；36(10)：1591-1594.
[75]胜兰,王鹏.大承气汤对肠源性肺损伤大鼠肺组织抗氧化保护作用的研究.湖北中医学院学报,2003；5(3)：21-22.
[2]Anthonisen NR etal. Antibiotic therapy in exacerbations of chronic ob structive pulmonary disease. Ann Intern Med,1987; 106(2):1962-204.
[3]唐昊,修清玉.慢性阻塞性肺疾病急性加重的研究.国际呼吸杂志,2007；27(3)：225-229.
[4]Bhowmik A, Seemungal A R, Sapsford J, etal. Relation of sputum inflam matory markers to symptoms and lung function changes in COPD exacerb ations. Thorax,2000; 55:114-120.
[5]Montuschi P. Exhaled 8-iso-sprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am Respir Crit Care Med,2000; 162:1175-1177.
[6]White AJ, Gompertz S, Stockley R A.Chronic obstructive pulmonary dis ease 6:Theaetiology of exacerbations of chronic obstructive pulmonar y disease. Thorax,2003; 58(1):73-80.
[7]A. Sonia Buist,etal. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease(2006)GOLD. Execut ive Committee.
[8]王景红,顾媛媛.2005-2007年我院慢性阻塞性肺疾病住院患者用药分析.中国医院用药评价与分析,2008；8(7)：502-505.
[9]侯冬青.老年慢性阻塞性肺病患者医院肺炎病原菌及耐药性分析.中国现代医学杂志,2006；16(7)：1083-1085.
[10]王秀香,杨敬平,卜宝英.老年COPD并社区获得性肺炎常见病原菌及耐药性分析.临床肺科杂志,2008；13(4)：426-427.
[11]程萍.老年COPD患者并发社区获得性肺炎常见病原菌及其耐药性分析.山东医药,2008；48(16)：52.
[12]马兴璇,刘春明,雷保中,等COPD急性加重期患者支气管肺泡灌洗液细菌培养及药敏结果分析.检验医学,2008；23(5)：525-527.
[13]欧阳瑶.慢性阻塞性肺疾病患者非发酵菌感染及耐药谱分析.中国综合临床,2003；19(7)：624-625.
[14]任亚娟.老年慢性阻塞性肺疾病急性加重期216例下呼吸道病原菌分析.陕西医学杂志,2008；37(9)：1165-1167.
[15]樊春月.COPD下呼吸道感染主要致病菌种耐药现状.临床肺科杂志,2008；13(1)：59-61.
[16]赵德军,付维婵,田维涛,等.老年COPD患者并发肺部真菌感染的相关因素分析及控制对策.西南军医,2008；10(5)：39.
[17]银春.茶碱的作用机制及在慢性阻塞性肺疾病中的应用.临床肺科杂志,2008；13(7)：885-887.
[18]赵健.糖皮质激素短期治疗AECOPD的临床疗效观察.中国医药导报,2008；5(11)：61.
[19]任建萍.慢性阻塞性肺疾病的经济负担及其影响因素研究.卫生经济研究,2002；10：16-17.
[20]叶静辉,李惠玲,郭瑞霞,等.慢性阻塞性肺疾病急性加重期经济负担与防治现状的卫生经济学分析中国预防医学杂志,2005；6(4)：364-366.
[21]李建生.中药治疗COPD急性加重期的系统评价.天津中医药,2008；25(5)：428-432.
[22]王贵勤.痰热清注射液治疗慢性阻塞性肺病急性加重期的临床观察.中国现代医生,2007；45(13)：146-147.
[23]谷春燕.中西医结合治疗慢性阻塞性肺疾病疗效分析.中国民康医学,2007；19(9)：759.
[24]梁爱武.冬屏汤冬病夏治对慢性阻塞性肺疾病稳定期免疫功能影响的观察.广西中医学院学报,2008;11(1)：9-11.
[25]李树强.中医治疗慢性阻塞性肺疾病研究概况.实用中医药杂志,2006；22(4)：248-249.
[26]孙子凯,曹世宏.262例慢性阻塞性肺疾病证治规律探讨.南京中医药大学学报,1998；14(1)：13-15.
[27]田正鉴,徐幼明,李亚清.慢性阻塞性肺疾病中医病机探微.湖北中医学院学报,2001；3(1)：29-30.
[28]薛汉荣.中医论治慢性阻塞性肺病.江西中医学院学报,2004；16(6)：13.
[29]田德禄主编.中医内科学,北京：人民卫生出版社,2006,第1版：98.
[30]王至婉.基于文献的慢性阻塞性肺疾病稳定期证候诊断标准研究.中医研究,2008;21(8)：55-58.
[31]黄东晖,吴蕾,何德平,等.中西医综合治疗慢性阻塞性肺疾病稳定期临床观察.第四军医大学学报,2005；26(17)：1611-1613.
[32]张颖,高鹏飞,方忠宏,等.益肺健脾补肾法为主防治慢性阻塞性肺疾病的疗效观察.中国中医基础医学杂志,2004；10(6)：56-57.
[33]刘小虹,刘琼.培土生金法在慢性阻塞性肺疾病缓解期的应用研究.新中医, 2002；34(10)：18.
[34]王胜,季红燕,张念志,等.益肺健脾方对炎症细胞计数和慢性阻塞性肺疾病患者痰液IL-8、TNF-a水平的影响.中国中西医结合杂志,2005；25(2)：111-113.
[35]王胜,季红燕,张念志,等.益肺健脾中药改善慢性阻塞性肺疾病患者肺功能及营养状况.中国临床康复,,2005；31(9)：141-143.
[36]朱渊红,王新华,朱奕豪,等.益气健脾方对慢性阻塞性肺病营养状态的影响.中国中西医结合杂志,2005；25(8)：759-760.
[37]李海明,张华茹.银杏叶片治疗慢性阻塞性肺疾病稳定期疗效观察.现代中西医结合杂志,2004；13(2)：146.
[38]李兴文,杨玉萍,方利洲,等.云南白药对稳定期慢性阻塞性肺疾病痰液炎性细胞调控研究.中国新药杂志,2001；10(4)：282-284.
[39]朱文翔.益气养阴法治疗肺胀病.湖北中医杂志,1996；(3)：41.
[40]朱频,郦永平.慢性阻塞性肺疾病急性加重期中医证治规律探讨.河南中医,1998；18(6)：369.
[41]陈凯佳.500例慢性阻塞性肺疾病中医证型规律探讨.现代中西医结合杂志,2002；11(18)：1755-1757.
[42]蔡敏.定掌汤治疗慢阻肺急性发作期160例临床研究.江苏中医药,2005；26(12)：18-19.
[43]陈艳波,王华,刘华,等.痰热清注射液治疗慢性阻塞性肺疾病临床研究.中国中医急症,2005；14(7)：620-621.
[44]崔焱,梁直英,董竞成.活血化瘀方治疗慢性阻塞性肺疾病急性加重期的临床观察.中国中西医结合杂志,2005；25(4)：327-329.
[45]林琳,方泓,吴银根.加味已椒苈黄汤治疗COPD肺动脉高压的临床研究.上海中医药杂志,2005；39(6)：24-25.
[46]付泽伟,王晓君.中西医结合治疗慢性阻塞性肺疾病继发真菌感染疗效观察.湖北中医杂志,2005；27(9)：36-37.
[47]史锁芳.COPD发作期治疗方案及组方新构想.中国中医药信息杂志,1998；5(12)：3-4.
[48]张元兵,洪广祥.“肺与大肠相表里”理论在慢性阻塞性肺疾病急性发作期的应用.江西中医药,2000；31(3)：15-17.
[49]李兴锋.下法在内科急症中的应用.实用中医内科杂志,2004；18(4)：328.
[50]李秀彦.通腑降浊法治疗慢性阻塞性肺疾病呼吸衰竭的疗效观察.河北中医,2006；28(7)：503-504.
[51]方堃.通腑平喘汤联合机械通气治疗慢性阻塞性肺疾病并发呼吸衰竭的临床疗效观察.中国中西医结合急救杂志,2006；13(5)：291-293.
[52]方堃.通腑平喘汤对COPD机械通气患者呼吸力学的作用.浙江中西医结合杂志,2008；18(8)：466-468.
[53]刘宇.益气通腑汤对脱机困难的COPD患者的临床研究.河南大学学报(医学科学版),2002；21(2)：29-31.
[54]张英兰.中药灌肠合无创通气治疗COPD并呼吸衰竭临床观察.实用中西医结合临床,2008；8(3)：13-14.
[55]林婕钊,韩云,李芳.通下法配合无创通气治疗慢性阻塞性肺疾病急性加重期呼吸衰竭15例.新中医,2005；37(1)：41-42.
[56]宋应西.通腑化瘀法治疗轻型肺性脑病31例.河南中医学院学报,2006；5：50-51.
[57]汪丙柱.从肺与大肠相表里论治慢性阻塞性肺疾病稳定期的临床观察.中国中医药信息杂志,2008；15(9)：76-77.
[58]陈宏,支开叶,冯五金.通腑泻热法治疗AECOPD128例临床观察.山西中医,2008；24(6)：29-30.
[59]张文东.小承气汤合清金化痰汤治疗慢性阻塞性肺疾病急性加重期42例.中医药临床杂志,2008；20(1)：39-40.
[60]韦蓉.通腑法治疗慢性阻塞性肺疾病继发缺氧性肺动脉高压疗效观察.中国中医急症,2007；16(11)：1311-1313.
[61]刘军.大承气汤治疗慢性阻塞性肺病腹胀的临床观察.临床肺科杂志,2007；12(11)：1188.
[62]王今达.祖国医学“肺与大肠相表里”学说的临床意义及其本质探讨.中西医结合杂志,1982；2(2)：77-78.
[63]王辉,郑水红,曹樟全.小承气汤对危重症腹胀患者呼吸功能的影响.浙江中西医结合杂志,2002;12(8)：482-483.
[64]苗裕,杨进.“肺与大肠相表里”理论论述及临床应用浅析.中国医药导报,2009；15(12)：7-9.
[65]韦慧,史肃育,吴同启.通腑法治疗慢性阻塞性肺疾病继发缺氧性肺动脉高压疗效观察.中国中医急症,2007；16(11)：1311.
[66]范仁忠.论通里泻下法在急重病证中的运用.中国中医急症,2000；9(2)：66-67.
[67]崔杰.小承气汤治疗慢性阻塞性肺病急性期的体会.河南中医,1999；19(4)：12.
[68]于德敏,范喜云.大黄对肺心病并发胃肠道衰竭的治疗观察.临床荟萃,1999；14(13)：614.
[69]张文东,许有志,金莉.小承气汤合清金化痰汤治疗慢性阻塞性肺疾病急性加重期42例.中医药临床杂志,2008；20(1)：39-40.
[70]李广彬.小承气汤的现代药理与临床应用.中国医药指南,2008；6(15)：136-137.
[71]杨岚,梁一木,陈明霞,等.氧化与抗氧化失衡对慢性阻塞性肺病患者外周血 淋巴细胞线粒体膜磷脂改变的研究.陕西医学杂志,1998；27(10)：589～592.
[72]李春盛,何新华,桂培春.大黄对急性肺损伤大鼠血浆和支气管肺泡灌洗液中炎症细胞因子表达的影响.中国中西医结合急救杂志,2005；12(5)：306-308.
[73]李贞茂,韩盛玺,徐志鹏,等.厚朴酚对大鼠坏死性胰腺炎肺损伤的保护作用.世界华人消化杂志,2006；14(12)：1167-1171.
[74]王立青,江荣高,陈蕙芳.厚朴酚与和厚朴酚药理作用的研究进展.中草药,2005；36(10)：1591-1594.
[75]胜兰,王鹏.大承气汤对肠源性肺损伤大鼠肺组织抗氧化保护作用的研究.湖北中医学院学报,2003；5(3)：21-22.